Abingdon Health Plc(ABDXF)
USD --+0.00%
Reward53Moderate
Risk51Moderate
📊75%Data
Thin -38% profit margin · Revenue growing 28% YoY
ABDXF
+0.0 · +0.00%
USD · PINK
Abingdon Health Plc | Healthcare
Profitless Growth
Market Cap:13.27M
ℹ️
Reward Rating
53
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
51
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ABDXF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Abingdon Health Plc?

Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.

ABDXF · Verdict

Moderate reward · elevated risk

ABDXF stands out on volatility and growth, but watch the cash flow signal.

Based on 88% data coverage

ABDXF · Verdict

What’s working & what to watch

Strengths 2

  • Volatility95/100

    Top decile vs peers

  • Growth68/100

    Rev +43.8% CAGR · earnings -45.6%

Watchouts 2

  • Cash flow6/100

    -42% free-cash-flow margin

  • Profitability19/100

    -41% net margin · -63% ROE

Model-based scoring. For information only — not financial advice.

What is Abingdon Health Plc?

Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 13.27M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (53)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap13.27M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.1375
52 Week Low0.07
Last AnnualJune
IPO DateN/A
IncorporatedUSA
Shares Outstanding190M
No. of Employees113
IndustryDiagnostics & Research
ExchangePINK
Beta0.184
CurrencyUSD · Reports in GBP